VATRELLA, Alessandro
 Distribuzione geografica
Continente #
AS - Asia 19.305
NA - Nord America 13.580
EU - Europa 3.659
SA - Sud America 874
AF - Africa 152
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 10
Totale 37.596
Nazione #
HK - Hong Kong 13.470
US - Stati Uniti d'America 13.420
SG - Singapore 2.476
CN - Cina 1.292
VN - Vietnam 918
IT - Italia 832
UA - Ucraina 686
BR - Brasile 655
DE - Germania 461
RU - Federazione Russa 452
FR - Francia 275
IE - Irlanda 269
TR - Turchia 263
KR - Corea 210
FI - Finlandia 181
SE - Svezia 178
IN - India 157
BD - Bangladesh 124
GB - Regno Unito 111
AR - Argentina 84
CA - Canada 63
MX - Messico 57
IQ - Iraq 56
JP - Giappone 52
TW - Taiwan 49
ZA - Sudafrica 46
NL - Olanda 39
EC - Ecuador 35
ES - Italia 33
AT - Austria 31
CO - Colombia 31
ID - Indonesia 30
PK - Pakistan 28
PL - Polonia 26
UZ - Uzbekistan 26
PH - Filippine 21
VE - Venezuela 21
LT - Lituania 19
TN - Tunisia 19
MA - Marocco 18
MY - Malesia 18
SA - Arabia Saudita 17
AU - Australia 15
DZ - Algeria 15
KE - Kenya 14
NP - Nepal 12
PE - Perù 12
PY - Paraguay 12
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
EG - Egitto 10
CL - Cile 9
JO - Giordania 9
CR - Costa Rica 8
EU - Europa 8
BE - Belgio 7
BH - Bahrain 7
ET - Etiopia 7
KZ - Kazakistan 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
OM - Oman 6
RO - Romania 6
BO - Bolivia 5
GR - Grecia 5
IL - Israele 5
JM - Giamaica 5
LB - Libano 5
KG - Kirghizistan 4
KW - Kuwait 4
NG - Nigeria 4
NI - Nicaragua 4
PT - Portogallo 4
AL - Albania 3
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
GY - Guiana 3
HN - Honduras 3
HU - Ungheria 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
AM - Armenia 2
BZ - Belize 2
DK - Danimarca 2
GE - Georgia 2
IR - Iran 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
Totale 37.562
Città #
Hong Kong 13.459
Ann Arbor 2.573
Singapore 1.282
Wilmington 1.147
Woodbridge 1.119
San Jose 1.015
Jacksonville 852
Chandler 851
Princeton 753
Ashburn 639
Houston 564
Dallas 563
Dong Ket 397
Council Bluffs 304
Beijing 283
Dublin 265
The Dalles 238
Lauterbourg 233
Izmir 226
Ho Chi Minh City 178
Moscow 169
Andover 166
Nanjing 159
Munich 154
Boardman 140
Dearborn 134
Pellezzano 125
Hanoi 120
Los Angeles 99
Salerno 94
New York 87
Naples 85
Mestre 81
Santa Clara 73
Düsseldorf 65
Fairfield 64
São Paulo 57
Shenyang 54
Hebei 52
Changsha 50
Memphis 50
Tokyo 47
Frankfurt am Main 45
Helsinki 43
Taipei 43
Nanchang 42
Norwalk 41
Jiaxing 39
Columbus 37
Orem 37
Redwood City 35
Pune 34
Tianjin 34
Milan 31
Johannesburg 29
Nuremberg 29
Seattle 29
Montreal 28
Da Nang 27
Rome 26
Baghdad 25
Chicago 25
Rio de Janeiro 25
Atlanta 24
Haiphong 24
Jinan 24
Boston 23
Dhaka 23
Falls Church 23
San Francisco 23
Shanghai 23
Warsaw 23
Brooklyn 22
Phoenix 22
Tashkent 22
Mexico City 21
Stockholm 21
Denver 20
London 20
Manchester 20
Washington 20
Amsterdam 18
Mumbai 18
Vienna 18
Cambridge 17
Chennai 17
Pollena Trocchia 16
Brasília 15
New Delhi 15
Belo Horizonte 14
Curitiba 14
Guangzhou 14
Charlotte 13
San Diego 13
Turku 13
Buffalo 11
Nairobi 11
Poplar 11
Toronto 11
Acerra 10
Totale 30.437
Nome #
Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma. 2.383
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 957
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 892
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications 824
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 687
Surgical approach in thymectomy: Our experience and review of the literature 621
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 578
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 569
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 566
Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma 559
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 484
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 483
Effects of statins and farnesyltransferase inhibitors on proliferation and ERK phosphorylation in non-small lung cancer cells. 448
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 434
Phenotyping severe asthma: a rationale for biologic therapy 429
The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine 427
Extrathoracic recurrence of type A thymoma 364
Application of Proteomics and Peptidomics to COPD 359
Severe eosinophilic asthma: From the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab 350
Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: report of two cases, literature review and new therapeutic strategies. 314
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 314
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 304
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 299
Social Networks, Asthma and Much More.. 297
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 293
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives 278
Novel Biological Therapies for Severe Asthma Endotypes 242
Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation 230
Asymmetric dimethylarginine (ADMA): Will be or will not be a new revolutionary biomarker of bronchial asthma? 222
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 203
Role of biologics in severe eosinophilic asthma – focus on reslizumab 184
Differential expression of RNA-binding proteins in airway epithelium in chronic lung inflammation 180
Age as a risk factor in the occurrence of pneumothorax after transthoracic fine needle biopsy: our experience 177
Effects of TGF-beta and budesonide on MAPK phosphorylation, IL-6/IL-11 secretion, and cell proliferation in human lung fibroblasts 171
A case of pulmonary hemangioendothelioma transformed into an epitheliod angiosarcoma. 168
Respiratory infections and asthma 166
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 165
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review 158
An Acute Bronchodilator Test with Tiotropium or Salmeterol Does Not Allow a Subdivision of Patients according to Responses 158
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 158
Detection of RAS mutation by pyrosequencing in thyroid cytology samples 157
Angiogenesis in Bronchial Biopsies of Symptomatic Smokers with and without Lung Cancer 155
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells 155
Vascular remodeling in bronchial mucosa of smokers with and without airway obstruction. 155
Angiogenetic and apoptotic process in the airways of symptomatic smokers with and without a contralateral non small cell lung cancer 155
Cushing's like syndrome in typical bronchial carcinoid a case report and review of the literature 154
Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. 152
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 148
Asthma: Targeted biological therapies 148
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 147
Allergy in urban elderly population living in Campania region (Southern Italy). A multicenter study 146
Effects of endothelin-1 on MAPK activation, IL-6 production and cell proliferation in normal human lung fibroblasts 145
Surgical management of cervico-mediastinal goiters: Our experience and review of the literature 145
[The lung in connectivitis]. 144
An insight into pharmacological and clinical basis of anti-IgE for add-on therapy of severe asthma 144
[Netilmicin in the treatment of respiratory infections]. 143
Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. 142
Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF- in primary cultures of human bronchial epithelial cells. 142
Characterization of peripheral subsets of dendritic cells in COPD patients: preliminary data 142
Climate change and air pollution: Effects on respiratory allergy 142
Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. 141
The role of calcium blockers in asthma prevention and therapy. 141
Small cell lung cancer associated with solitary fibrous tumors of the pleura: A case study and literature review 141
Airway Remodelling in Asthma 138
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 137
Protective effect of levodropropizine against cough induced by inhalation of nebulized distilled water in patients with obstructive lung disease. 136
Exhaled nitric oxide after inhalation of isotonic and hypotonic solutions in healthy subjects. 135
[Heterogeneity of microbial flora responsible for respiratory infections in AIDS]. 135
The potential of biologics for the treatment of asthma 135
Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD. 133
Asthma-related deaths 133
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma. 132
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. 132
Audit on the appropriateness of integrated COPD management: The "aLT-BPCO" project 131
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases. 130
Bronchial vascularity in the airways of chronic bronchitis and COPD smokers 130
Negative and Positive Role of Social Network in Asthma Patients 130
Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells. 129
Near fatal asthma: Treatment and prevention 129
Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics. 128
The effects of adding formoterol (F) and tiotropium (T) on exercise performance and breathlessness in patients with COPD 128
Sirtuin 1 and aging theory for chronic obstructive pulmonary disease 128
COPD: Maximization of bronchodilation 128
New perspectives in asthma treatment. 127
Recurrent respiratory infections caused by a double aortic arch: The diagnostic role of spirometry 127
SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease 127
Cytological diagnosis of the thyroidal nodule: A review 127
Vascular remodelling in COPD airways 126
Increased activation of p38 MAPK in COPD 125
Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells. 125
Post-pneumonectomy broncho-pleural fistula successfully closed by open-window thoracostomy associated with V.A.C. therapy. 125
[The role of neutrophils in the pathogenesis of chronic pulmonary emphysema]. 123
[A case of pulmonary fibrosis]. 122
Negative and positive role of social network in asthma patients 122
Update on Effects of Climate Changes on Respiratory Allergy 122
Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer. 122
Allergenic pollen and pollen allergy in Europe 122
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 122
Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β 121
Pulmonary arterovenous malformation causing hemothorax in a pregnant woman without Osler-Weber-Rendu syndrome 120
Totale 25.221
Categoria #
all - tutte 104.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021452 0 0 0 0 0 0 0 0 0 0 0 452
2021/20221.272 0 2 7 18 23 43 25 55 186 163 170 580
2022/20232.072 220 131 61 255 254 465 8 210 308 19 98 43
2023/20241.019 99 130 62 61 60 131 50 101 14 51 41 219
2024/20253.225 69 57 47 99 104 316 422 286 452 183 244 946
2025/202620.782 4.419 5.535 4.182 604 1.183 567 1.828 355 534 1.152 308 115
Totale 38.068